|
Volumn 80, Issue 3, 2001, Pages
|
Report on workshop: UICC workshop "therapy of NHL in early stages". Part 1: Follicular lymphoma
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RITUXIMAB;
TUMOR VACCINE;
ANTINEOPLASTIC AGENT;
CANCER CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONFERENCE PAPER;
FOLLICULAR LYMPHOMA;
HISTOPATHOLOGY;
HUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
SURVIVAL RATE;
WHOLE BODY RADIATION;
ADJUVANT THERAPY;
MORTALITY;
PATHOLOGY;
PROSPECTIVE STUDY;
RETROSPECTIVE STUDY;
SURVIVAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DISEASE-FREE SURVIVAL;
HUMAN;
LYMPHOMA, FOLLICULAR;
PROSPECTIVE STUDIES;
RADIOTHERAPY, ADJUVANT;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
WHOLE-BODY IRRADIATION;
|
EID: 0035195982
PISSN: 09458077
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (7)
|
References (20)
|